MTD
METTLER TOLEDO INTERNATIONAL INC/
NYSE · Healthcare · Medical - Diagnostics & Research · US
$1,392.32
−1.28%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- $12
- Revenue estimate
- $1.1B
Latest reported
- Last report date
- Jul 31, 2026
- EPS actual
- $11
- EPS estimate
- $11
- Revenue actual
- $1.0B
- Revenue estimate
- $1.0B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +4.5%
- Revenue beats (12Q)
- 7
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $1.5K
- PT range
- $1.2K – $1.6K
- Analysts
- 9
5 Buy3 Hold1 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 31, 2026 | $11 | $11 | Beat 6.30% | $1.0B |
| May 8, 2026 | $8.70 | $8.91 | Beat 2.46% | $947.1M |
| Feb 5, 2026 | $13 | $13 | Beat 4.56% | $1.1B |
| Nov 6, 2025 | $11 | $11 | Beat 4.52% | $1.0B |
| Jul 31, 2025 | $9.61 | $10 | Beat 4.97% | $983.2M |
| May 1, 2025 | $7.92 | $8.19 | Beat 3.47% | $883.7M |
| Feb 6, 2025 | $12 | $12 | Beat 6.42% | $1.0B |
| Nov 8, 2024 | $9.99 | $10 | Beat 2.20% | $954.5M |
| Aug 1, 2024 | $9.04 | $9.65 | Beat 6.71% | $946.8M |
| May 9, 2024 | $7.66 | $8.89 | Beat 16.13% | $925.9M |
| Feb 8, 2024 | $10 | $9.40 | Miss -7.46% | $935.0M |
| Nov 9, 2023 | $9.78 | $9.80 | Beat 0.26% | $942.5M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026